ID   HYES_PIG                Reviewed;         555 AA.
AC   Q6Q2C2;
DT   07-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   10-FEB-2021, entry version 99.
DE   RecName: Full=Bifunctional epoxide hydrolase 2;
DE   Includes:
DE     RecName: Full=Cytosolic epoxide hydrolase 2;
DE              Short=CEH;
DE              EC=3.3.2.10 {ECO:0000250|UniProtKB:P34913};
DE     AltName: Full=Epoxide hydratase;
DE     AltName: Full=Soluble epoxide hydrolase;
DE              Short=SEH;
DE   Includes:
DE     RecName: Full=Lipid-phosphate phosphatase;
DE              EC=3.1.3.76 {ECO:0000250|UniProtKB:P34913};
GN   Name=EPHX2;
OS   Sus scrofa (Pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Suina; Suidae; Sus.
OX   NCBI_TaxID=9823;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   TISSUE=Ovary;
RX   PubMed=15308618; DOI=10.1210/en.2004-0710;
RA   Newman J.W., Stok J.E., Vidal J.D., Corbin C.J., Huang Q., Hammock B.D.,
RA   Conley A.J.;
RT   "Cytochrome p450-dependent lipid metabolism in preovulatory follicles.";
RL   Endocrinology 145:5097-5105(2004).
CC   -!- FUNCTION: Bifunctional enzyme. The C-terminal domain has epoxide
CC       hydrolase activity and acts on epoxides (alkene oxides, oxiranes) and
CC       arene oxides. Plays a role in xenobiotic metabolism by degrading
CC       potentially toxic epoxides (By similarity). Also determines steady-
CC       state levels of physiological mediators (PubMed:15308618). The N-
CC       terminal domain has lipid phosphatase activity, with the highest
CC       activity towards threo-9,10-phosphonooxy-hydroxy-octadecanoic acid,
CC       followed by erythro-9,10-phosphonooxy-hydroxy-octadecanoic acid, 12-
CC       phosphonooxy-octadec-9Z-enoic acid and 12-phosphonooxy-octadec-9E-enoic
CC       acid (By similarity). {ECO:0000250|UniProtKB:P34913,
CC       ECO:0000250|UniProtKB:P80299, ECO:0000305|PubMed:15308618}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an epoxide + H2O = an ethanediol; Xref=Rhea:RHEA:19037,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:32955, ChEBI:CHEBI:140594;
CC         EC=3.3.2.10; Evidence={ECO:0000250|UniProtKB:P34913};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9S,10S)-10-hydroxy-9-(phosphooxy)octadecanoate + H2O =
CC         (9S,10S)-9,10-dihydroxyoctadecanoate + phosphate;
CC         Xref=Rhea:RHEA:16537, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:58796, ChEBI:CHEBI:58797; EC=3.1.3.76;
CC         Evidence={ECO:0000250|UniProtKB:P34913};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(14R,15S)-epoxy-(5Z,8Z,11Z)-eicosatrienoate + H2O = (14R,15R)-
CC         dihydroxy-(5Z,8Z,11Z)-eicosatrienoate; Xref=Rhea:RHEA:53976,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:131965, ChEBI:CHEBI:138003;
CC         Evidence={ECO:0000250|UniProtKB:P34914};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53977;
CC         Evidence={ECO:0000250|UniProtKB:P34914};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P34913};
CC   -!- ACTIVITY REGULATION: Inhibited by 1-(1-acetylpiperidin-4-yl)-3-(4-
CC       (trifl uoromethoxy)phenyl)urea (TPAU), 1-cyclohexyl-3-dodecylurea
CC       (CDU), 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA), 1-((3S, 5S,
CC       7S)-adamantan-1-yl)-3-(5-(2-(2-ethoxyethoxy) ethoxy)pentyl)urea (AEPU),
CC       N-adamantyl-N[']-cyclohexyl urea (ACU), 4-(((1S, 4S)-4-(3-((3S, 5S,
CC       7S)-adamantan-1-yl) ureido)cyclohexyl)oxy)benzoic acid (c-AUCB), 4-
CC       (((1R, 4R)-4-(3-((3S, 5S, 7S)-adamantan-1-
CC       yl)ureido)cyclohexyl)oxy)benzoic acid (t-AUCB), 4-(((1R, 4R)-4-(3-
CC       (4(trifluoromethoxy)phenyl)ureido)cyclohexyl)oxy)benzoic acid (t-TAUCB)
CC       and to a lesser extent by 8-(3-((3S, 5S, 7S)-adamantan-1-yl)ureido)
CC       octanoic acid (AUOA). {ECO:0000250|UniProtKB:P34913}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P34913}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Peroxisome
CC       {ECO:0000250}.
CC   -!- DOMAIN: The N-terminal domain has phosphatase activity. The C-terminal
CC       domain has epoxide hydrolase activity.
CC   -!- PTM: The covalent modification of cysteine by 15-deoxy-Delta12,14-
CC       prostaglandin-J2 is autocatalytic and reversible. It may occur as an
CC       alternative to other cysteine modifications, such as S-nitrosylation
CC       and S-palmitoylation (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the AB hydrolase superfamily. Epoxide hydrolase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY566232; AAS68016.1; -; mRNA.
DR   RefSeq; NP_001001641.1; NM_001001641.1.
DR   SMR; Q6Q2C2; -.
DR   STRING; 9823.ENSSSCP00000010323; -.
DR   BindingDB; Q6Q2C2; -.
DR   ESTHER; pig-q6q2c2; Epoxide_hydrolase.
DR   MEROPS; S33.973; -.
DR   PaxDb; Q6Q2C2; -.
DR   PeptideAtlas; Q6Q2C2; -.
DR   PRIDE; Q6Q2C2; -.
DR   Ensembl; ENSSSCT00070046106; ENSSSCP00070038885; ENSSSCG00070023132.
DR   GeneID; 414425; -.
DR   KEGG; ssc:414425; -.
DR   CTD; 2053; -.
DR   eggNOG; KOG3085; Eukaryota.
DR   eggNOG; KOG4178; Eukaryota.
DR   InParanoid; Q6Q2C2; -.
DR   OrthoDB; 616687at2759; -.
DR   Proteomes; UP000008227; Unplaced.
DR   Proteomes; UP000314985; Chromosome 14.
DR   GO; GO:0005777; C:peroxisome; IEA:UniProtKB-SubCell.
DR   GO; GO:0033885; F:10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004301; F:epoxide hydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0042577; F:lipid phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; ISS:UniProtKB.
DR   GO; GO:0019439; P:aromatic compound catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0046839; P:phospholipid dephosphorylation; ISS:UniProtKB.
DR   GO; GO:0009636; P:response to toxic substance; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.150.240; -; 1.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR000073; AB_hydrolase_1.
DR   InterPro; IPR000639; Epox_hydrolase-like.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR006439; HAD-SF_hydro_IA.
DR   InterPro; IPR011945; HAD-SF_ppase_IA/epoxid_hydro_N.
DR   InterPro; IPR041492; HAD_2.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR023198; PGP-like_dom2.
DR   Pfam; PF00561; Abhydrolase_1; 1.
DR   Pfam; PF13419; HAD_2; 1.
DR   PRINTS; PR00111; ABHYDROLASE.
DR   PRINTS; PR00412; EPOXHYDRLASE.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   TIGRFAMs; TIGR02247; HAD-1A3-hyp; 1.
DR   TIGRFAMs; TIGR01509; HAD-SF-IA-v3; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Aromatic hydrocarbons catabolism; Cytoplasm; Detoxification;
KW   Hydrolase; Lipid metabolism; Lipoprotein; Magnesium; Metal-binding;
KW   Multifunctional enzyme; Peroxisome; Phosphoprotein; Reference proteome.
FT   CHAIN           1..555
FT                   /note="Bifunctional epoxide hydrolase 2"
FT                   /id="PRO_0000084113"
FT   DOMAIN          259..531
FT                   /note="AB hydrolase-1"
FT                   /evidence="ECO:0000255"
FT   REGION          1..224
FT                   /note="Phosphatase"
FT   REGION          123..124
FT                   /note="Phosphate binding"
FT                   /evidence="ECO:0000250|UniProtKB:P34913"
FT   REGION          235..555
FT                   /note="Epoxide hydrolase"
FT   MOTIF           553..555
FT                   /note="Microbody targeting signal"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        335
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:P34913"
FT   ACT_SITE        466
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P34913"
FT   ACT_SITE        524
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P34913"
FT   METAL           9
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000250|UniProtKB:P34913"
FT   METAL           11
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000250|UniProtKB:P34913"
FT   METAL           185
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000250|UniProtKB:P34913"
FT   BINDING         383
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P34913"
FT   MOD_RES         43
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P34913"
FT   MOD_RES         191
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P34914"
FT   MOD_RES         215
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P34914"
FT   MOD_RES         370
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P34914"
FT   MOD_RES         455
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P34914"
FT   MOD_RES         505
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P34914"
FT   MOD_RES         554
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P34914"
FT   LIPID           522
FT                   /note="S-(15-deoxy-Delta12,14-prostaglandin J2-9-
FT                   yl)cysteine"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   555 AA;  62767 MW;  996EF83CBF82FBEF CRC64;
     MALRAAVFDL DGVLALPSIT TSWARAEEKL ALPRGFLNEA FKKGGQDGSV ARVMTGEITF
     SQWVPFMEED CRKCAEDSGI RLPENFSVKH IFDKALSEKK INYPMLQAAL TLKKKGFSTC
     ILTNNWLDDS AQRGSRAQLM CELRPHFDFL IESCRVGMAK PDPQIYKLML DTLKAEPNEV
     VFLDDVGTHL KPVRDLGMAT ILVRDTDTAL RELEKVTGVQ LLQTPALPPT SCDPSALSHG
     YVLIKPGVRL HFVEMGSGPA VCLCHGFPES WFSWRYQIPA LAQAGFRVLA VDMKGYGESS
     APPEIEEYSL EVLCKDMVTF LNKLGLSQAV FIGHDWGGVL VWNMALFYPE RVRAVASLNT
     PFMPSNPNVS PMEIIKANPV FDYQLYFQEP GVAEAELEQN LDRTFKNFFR AHDETFLTTN
     RVRELGGLFV GTPEEPSLSR LVTEEDIQFY VQQFKKSGFR GPLNWYRNME RNWQWGCKGS
     GRKILIPALM VTAENDLVLH PKMSKHMENW IPHLKRGHIK DCGHWTQIDK PAELNRILIE
     WLETDARNPL VDSKL
//
